Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
Viridian Therapeutics has scored an FDA
956 words~4 min read
Other newsrooms on this story
· 4 sources
biopharmadive.com·
Viridian may have edge over Amgen in eye drug showdown, analysts argue
benzinga.com·
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease - Virid
endpoints.news·
FDA approves Viridian eye drug, stoking competition with Amgen's Tepezza
morningstar.com·
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
